CDH5 and rheumatoid arthritis: In addition, MMP-catalyzed VE-cadherin cleavage results in the generation of soluble VE-cadherin, which itself can further destabilize the vascular barrier by impairing the binding of VE-cadherin molecules, as shown in human rheumatoid arthritis, systemic inflammation, and sepsis [145,146,147].